{"id":"W2114027444","doi":"10.2337/dc13-2855","title":"Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study","year":2014,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Sitagliptin; Type 2 diabetes; Internal medicine; Regimen; Dulaglutide; Dipeptidyl peptidase-4 inhibitor; Clinical endpoint; Adverse effect; Diabetes mellitus; Renal function; Nausea; Gastroenterology; Liraglutide; Endocrinology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592446,0.00163327,0.004365664,0.0004753391,0.0004441826,0.001263825,0.001118251,0.001864464,0.004315675],"category_scores_gemma":[0.001895237,0.0007610666,0.002256984,0.0005431144,0.001245621,0.001275145,0.0003937604,0.003463282,0.0008506463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006803073,"about_ca_system_score_gemma":0.001390954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005987204,"about_ca_topic_score_gemma":0.001172386,"domain_scores_codex":[0.9991602,0.0004518403,0.00006538692,0.0001376654,0.00007481664,0.0001101767],"domain_scores_gemma":[0.9984015,0.0004369178,0.0003809367,0.000136389,0.00008497226,0.0005592952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9757413,0.008466979,0.0006247743,0.0002363041,0.000677213,0.00002639509,0.00003176941,0.0002927412,0.002380906,0.00002733676,0.0002790398,0.01121525],"study_design_scores_gemma":[0.9188952,0.07868069,0.001320646,0.00001225662,0.0002627528,0.00002305252,0.00001187975,0.0003614848,0.0002584774,0.00004200714,0.0001235506,0.000007907139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920482,0.002641744,0.0006452521,0.0004480905,0.0002595999,0.002345463,0.0005372549,0.0001234189,0.0009509943],"genre_scores_gemma":[0.989894,0.001721543,0.00163108,0.001131877,0.0004322528,0.00324884,0.0007599854,0.00003652889,0.001143984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004365664,"threshold_uncertainty_score":0.01443738,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00594548738920311,"score_gpt":0.2305715178757798,"score_spread":0.2246260304865767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}